Modified combination of platelet count and neutrophil "to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer

Head Neck. 2018 Jun;40(6):1138-1146. doi: 10.1002/hed.25085. Epub 2018 Jan 31.

Abstract

Background: We evaluated the prognostic potential of the combination of platelet count and neutrophil to lymphocyte ratio (COP-NLR) in patients with advanced head and neck cancer.

Methods: We proposed a modified COP-NLR scoring system defined as follows: score 0 (platelet count level <300 × 109 /L and NLR <3); score 1 (platelet count level ≥300 × 109 /L and NLR <3); and score 2 (NLR ≥3). We assessed whether the modified scoring system had better performance as an indicator of prognosis than the existing COP-NLR scoring system (original and 4-group scores).

Results: A total of 248 patients were enrolled. The Akaike Information Criterion value with the modified COP-NLR score was the smallest among the 3 models. The 3-year survival rates according to the modified COP-NLR scores of 0, 1, and 2 were 80.6%, 59.9%, and 23.8%, respectively.

Conclusion: The modified COP-NLR score is a useful prognostic marker in patients with advanced head and neck cancer.

Keywords: advanced head and neck cancer; hazard ratio; modified combination of platelet count and neutrophil to lymphocyte ratio (COP-NLR); overall survival; prognostic factor.

MeSH terms

  • Aged
  • Female
  • Head and Neck Neoplasms / blood*
  • Head and Neck Neoplasms / mortality
  • Head and Neck Neoplasms / pathology*
  • Humans
  • Lymphocyte Count*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Neutrophils*
  • Prognosis
  • Survival Rate